A cost-effectiveness analysis of escitalopram as first line treatment of depression in Sweden

By Löthgren Mickael   Hemels Michiel   François Clément   Jönsson Bengt  

Primary Care Psychiatry, Vol. 9, Iss. 4, 2004-12 ,pp. : 153-162

Informa Healthcare

Access to resources Recommend Favorite

Developing models for assessing the cost-effectiveness of antidepressants in primary care

By Thornett Andrew  

Primary Care Psychiatry, Vol. 7, Iss. 2, 2001-07 ,pp. : 69-74

Informa Healthcare

Access to resources Recommend Favorite

Cost-effectiveness of mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in Austria

By Brown M.C.J.   Nimmerrichter A.A.   Guest J.F.  

European Psychiatry, Vol. 14, Iss. 4, 1999-07 ,pp. : 230-244

Elsevier

Access to resources Recommend Favorite

A Danish cost-effectiveness model of escitalopram in comparison with citalopram and venlafaxine as first-line treatments for major depressive disorder in primary care

By Sørensen Jan   Stage Kurt   Damsbo Niels   Lay Agathe Le   Hemels Michiel  

Nordic Journal of Psychiatry, Vol. 61, Iss. 2, 2007-01 ,pp. : 100-108

Informa Healthcare

Access to resources Recommend Favorite

Assessing the effectiveness of the "human givens" approach in treating depression: a quasi experimental study in primary care

By Tsaroucha Anna   Kingston Paul   Stewart Tony   Walton Ian   Corp Nadia  

Mental Health Review Journal, Vol. 17, Iss. 2, 2012-06 ,pp. : 90-103

Emerald Group Publishing Ltd

Access to resources Recommend Favorite